Acropolis Investment Management, LLC Bristol Myers Squibb CO Transaction History
Acropolis Investment Management, LLC
- $1.67 Billion
- Q4 2024
A detailed history of Acropolis Investment Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Acropolis Investment Management, LLC holds 34,009 shares of BMY stock, worth $1.83 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
34,009
Previous 24,445
39.12%
Holding current value
$1.83 Million
Previous $1.27 Million
52.02%
% of portfolio
0.12%
Previous 0.08%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,729Shares Held
1.57BCall Options Held
30MPut Options Held
31.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.55 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.18 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.13 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.25 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...